Qing Zhou

4.6k total citations
101 papers, 3.2k citations indexed

About

Qing Zhou is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Biomedical Engineering. According to data from OpenAlex, Qing Zhou has authored 101 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 23 papers in Pulmonary and Respiratory Medicine and 18 papers in Biomedical Engineering. Recurrent topics in Qing Zhou's work include Nanoparticle-Based Drug Delivery (13 papers), Nanoplatforms for cancer theranostics (9 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers). Qing Zhou is often cited by papers focused on Nanoparticle-Based Drug Delivery (13 papers), Nanoplatforms for cancer theranostics (9 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers). Qing Zhou collaborates with scholars based in China, United States and Norway. Qing Zhou's co-authors include Alexander Revzin, Xiangliang Yang, Christian Siltanen, Jeffrey Kirsch, Aleksandr Simonian, Huibi Xu, Ying Liu, Ali Rahimian, Yanhong Zhu and Dong‐Sik Shin and has published in prestigious journals such as Chemical Society Reviews, Nature Communications and PLoS ONE.

In The Last Decade

Qing Zhou

95 papers receiving 3.2k citations

Peers

Qing Zhou
Han Chang Kang South Korea
Huan Wang China
Lei Li China
Haolu Wang Australia
Yi Zhao China
Wei Xie China
Qing Zhou
Citations per year, relative to Qing Zhou Qing Zhou (= 1×) peers Xiaojing Zhao

Countries citing papers authored by Qing Zhou

Since Specialization
Citations

This map shows the geographic impact of Qing Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Zhou more than expected).

Fields of papers citing papers by Qing Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Zhou. The network helps show where Qing Zhou may publish in the future.

Co-authorship network of co-authors of Qing Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Qing Zhou. A scholar is included among the top collaborators of Qing Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing Zhou. Qing Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ge, Min, et al.. (2024). QTc interval prolongation and risk of atrial fibrillation recurrence: a meta-analysis and observational cohort study. Frontiers in Cardiovascular Medicine. 11. 1483591–1483591.
3.
Ren, Xuefeng, et al.. (2024). Regulation of PPARγ/RXRα signaling pathway by Huaji Jianpi decoction in the prevention and treatment of simple obesity. Chinese Journal of Analytical Chemistry. 52(12). 100466–100466.
4.
Wang, Qi, Kai Wang, Qing Zhou, et al.. (2024). Localized Administration of Bcar3 siRNA via Nano-Self-Assembly to Treat Idiopathic Pulmonary Fibrosis by Disrupting Macrophage-Fibroblast Crosstalk. International Journal of Nanomedicine. Volume 19. 1827–1842. 7 indexed citations
5.
Wu, Bo, Wenxi He, Jia Gao, et al.. (2023). Selenium Biofortification Enhanced miR167a Expression in Broccoli Extracellular Vesicles Inducing Apoptosis in Human Pancreatic Cancer Cells by Targeting IRS1. International Journal of Nanomedicine. Volume 18. 2431–2446. 24 indexed citations
6.
Zhang, Jing, Longmin Chen, Qianqian Xu, et al.. (2023). Ubc9 regulates the expression of MHC II in dendritic cells to enhance DSS-induced colitis by mediating RBPJ SUMOylation. Cell Death and Disease. 14(11). 737–737. 2 indexed citations
7.
Zhang, Jing, Yuan Zou, Longmin Chen, et al.. (2023). Myo9b mutations are associated with altered dendritic cell functions and increased susceptibility to autoimmune diabetes onset. Nature Communications. 14(1). 5977–5977. 6 indexed citations
9.
Hu, Yinan, Qi Wang, Jun Yu, et al.. (2022). Tartrate-resistant acid phosphatase 5 promotes pulmonary fibrosis by modulating β-catenin signaling. Nature Communications. 13(1). 41 indexed citations
10.
Huang, Teng, Jia Song, Jia Gao, et al.. (2022). Adipocyte-derived kynurenine promotes obesity and insulin resistance by activating the AhR/STAT3/IL-6 signaling. Nature Communications. 13(1). 3489–3489. 86 indexed citations
11.
Sun, Fei, Faxi Wang, He Zhu, et al.. (2022). SUMOylation of PDPK1 Is required to maintain glycolysis-dependent CD4 T-cell homeostasis. Cell Death and Disease. 13(2). 181–181. 14 indexed citations
12.
Huang, Teng, Jia Gao, Hao Xie, et al.. (2022). Treating Pulmonary Fibrosis with Non-Viral Gene Therapy: From Bench to Bedside. Pharmaceutics. 14(4). 813–813. 8 indexed citations
13.
Xie, Hao, Yuhan Wang, Xin Liu, et al.. (2022). SUMOylation of ERp44 enhances Ero1α ER retention contributing to the pathogenesis of obesity and insulin resistance. Metabolism. 139. 155351–155351. 14 indexed citations
14.
Yue, Tiantian, Fei Sun, Faxi Wang, et al.. (2021). MBD2 acts as a repressor to maintain the homeostasis of the Th1 program in type 1 diabetes by regulating the STAT1-IFN-γ axis. Cell Death and Differentiation. 29(1). 218–229. 26 indexed citations
15.
Shen, Zhaofeng, et al.. (2019). Traditional Chinese medicine for mild-to-moderate ulcerative colitis. Medicine. 98(33). e16881–e16881. 15 indexed citations
16.
Wu, Qingzhi, et al.. (2015). Water-soluble l-cysteine-coated FePt nanoparticles as dual MRI/CT imaging contrast agent for glioma. International Journal of Nanomedicine. 10. 2325–2325. 36 indexed citations
17.
Liu, Chang, Zhaohui Du, Qing Zhou, et al.. (2014). Microscopic examination of intracellular organisms in bronchoalveolar lavage fluid for the diagnosis of ventilator-associated pneumonia: a prospective multi-center study. Chinese Medical Journal. 127(10). 1808–1813. 4 indexed citations
18.
Zhu, Yanhong, Qing Zhou, Hai Yang, et al.. (2010). Lactoferrin-conjugated superparamagnetic iron oxide nanoparticles as a specific MRI contrast agent for detection of brain glioma in vivo. Biomaterials. 32(2). 495–502. 136 indexed citations
19.
Zhang, Guolong, Yanfeng Zou, Xiao-Liang Feng, et al.. (2010). Association of the NFKBIA gene polymorphisms with susceptibility to autoimmune and inflammatory diseases: a meta-analysis. Inflammation Research. 60(1). 11–18. 22 indexed citations
20.
Li, Jianguo, Yanlin Wang, Zhengfang Hu, et al.. (2008). THE PROTECTIVE EFFECT OF THE CHOLINERGIC ANTI-INFLAMMATORY PATHWAY AGAINST SEPTIC SHOCK IN RATS. Shock. 30(4). 468–472. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026